// App-Quantinova.ai

195 : Apparent high frequency of disease flare following switch from reference biologic rituximab (Mabthera) to a biosimilar (Truxima) in patients with vasculitis

Researchers

Presenter

  • Sarah Tansley

Principal Investigators

  • Sarah Smith

  • Deborah Bond

  • Eleanor Korendowych

Medical Centers

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

  • Rituximab-abbs

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved